Compare SAP SE (SAP) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
SAP SE vs GeneDx Holdings Corp — how do they compare? SAP SE trades at $207.55 (market cap $245.39B), while GeneDx Holdings Corp trades at $86.53 (market cap $2.58B). The key difference: SAP SE is far larger — about 95.1× GeneDx Holdings Corp's market cap, and SAP SE pays a 1.4% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals.
| SAP | WGS | |
|---|---|---|
Market Cap | $245.39B | $2.58B |
Sector | Technology | Technology |
52-Week High | $280.46 | $167.51 |
52-Week Low | $146.38 | $34.51 |
Enterprise Value | $244.09B | $2.61B |
Dividend Yield | 1.4% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
SAP trades at $211.55, down 1.66% today, near the consensus price target of $209.67. The stock shows mixed signals with a neutral technical outlook, strong profitability margins above 20%, and recent earnings beating expectations in two of the last three quarters. Cloud revenue growth and AI initiatives are key drivers, supported by a €10 billion buyback program through 2027.
Outlook is cautiously optimistic with upside to the high target of $242, but risks include slower AI monetization and competitive pressures. Investors should weigh robust fundamentals against near-term execution challenges in a volatile software sector.
WGS trades at $85.87, down 0.14% on the day, with a bullish technical signal from moving averages and support at $84. The company reported Q2 2026 revenue of $114.4 million, beating estimates, and achieved adjusted profitability ahead of schedule. Recent news highlights partnerships and product launches, such as the NPC GenomeComplete initiative with Beren Therapeutics, driving positive sentiment.
Outlook is cautiously optimistic due to strong analyst support (90.9% buy ratings) and revenue growth, but risks include negative net income margins, high valuation multiples, and ongoing class action lawsuits. The stock's upside potential hinges on sustained operational improvements and market expansion in genomics diagnostics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About SAP SE
Founded in 1972 by former IBM employees, SAP provides database technology and enterprise resource planning software to enterprises around the world. Across more than 180 countries, the company serves 440,000 customers, approximately 80% of which are small to medium-size enterprises.
Read more on SAP →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
